NCT02393937 - A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea | Biotech Hunter

Enrollment

963

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

October 31, 2015

Conditions

Papulopustular RosaceaErythematotelangiectatic Rosacea

Interventions

DRUG

Reference: Metronidazole Gel 1%

Participants are assigned to one of three groups in parallel for the duration of the study

DRUG

Test: Metronidazole Gel 1%

Participants are assigned to one of three groups in parallel for the duration of the study

DRUG

Placebo Gel

Participants are assigned to one of three groups in parallel for the duration of the study

Trial Locations (27)

10075

New York

19103

Philadelphia

22203

Arlington

23507

Norfolk

27262

High Point

27612

Raleigh

29464

Mt. Pleasant

33126

Miami

33136

Miami

33486

Boca Raton

33634

Tampa

33761

Clearwater

34471

Ocala

40509

Lexington

45246

Cincinnati

75093

Plano

77055

Houston

78229

San Antonio

78660

Pflugerville

78759

Austin

79902

El Paso

89104

Las Vegas

90036

Los Angeles

92121

San Diego

33027q

Miramar

02472

Watertown

02886

Warwick

All Listed Sponsors

lead

bioRASI, LLC

INDUSTRY